Antithrombin Market by : Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

  • ID: 4531881
  • Report
  • Region: Global
  • 110 pages
  • Zion Market Research
1 of 3
The report covers forecast and analysis for the antithrombin market on a global and regional level. The study provides historic data of 2016 along with a forecast from 2017 to 2022 based revenue (USD Million). The study includes drivers and restraints for the antithrombin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the antithrombin market on a global level.

In order to give the users of this report a comprehensive view of the antithrombin market, we have to include competitive landscape and analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein source, application segments, and dosage form segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions mergers, new technology launch, agreements, partnerships, collaborations joint ventures, research development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

The study provides a decisive view on the antithrombin market by segmenting the market based on source, application, dosage form, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2022. Based on the source the market is segmented into human, and goat milk. Key application covered under this study includes diagnostics, therapeutics, and research. By dosage form, the market is segmented into liquid and lyophilized.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for antithrombin based on source, application, and dosage form in all the regions and countries.

The report also includes detailed profiles of end players such as Grifols, rEVO Biologics Inc., Shire plc., Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc., and Lee Biosolutions among others.

Global Antithrombin Market: Source Segment Analysis:
Human
Goat Milk

Global Antithrombin Market: Application Segment Analysis:
Diagnostics
Therapeutics
Research

Global Antithrombin Market: Dosage Form Segment Analysis:
Liquid
Lyophilized

Global Antithrombin Market: Regional Segment Analysis:
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology

2. Executive Summary
2.1. Global antithrombin market, 2016 2022 (USD Million)
2.2. Global antithrombin market : Snapshot

3. Antithrombin Market Dynamics
3.1. Introduction
3.2. Market drivers
3.2.1. Global antithrombin market drivers: Impact analysis
3.2.2. Increasing use of antithrombin as a combination therapy
3.2.3. Significant adoption of antithrombin therapies
3.3. Market restraints
3.3.1. Global antithrombin market restraints: Impact analysis
3.3.2. Usage of substitute and conventional anticoagulants
3.3.3. Pricing Pressure
3.4. Opportunities
3.4.1. Rising chronic diseases
3.5. Porters five forces analysis
3.5.1. Bargaining power of suppliers
3.5.2. Bargaining power of buyers
3.5.3. Threat from new entrants
3.5.4. Threat from new substitutes
3.5.5. Degree of competition
3.6. Market attractiveness analysis
3.6.1. Market attractiveness analysis, by source segment
3.6.2. Market attractiveness analysis, by application segment
3.6.3. Market attractiveness analysis, by dosage form segment
3.6.4. Market attractiveness analysis, by regional segment

4. Global Antithrombin Market Competitive Landscape
4.1. Company Market Share Analysis
4.1.1. Global antithrombin market: company market share, 2016
4.2. Strategic Development
4.2.1. Acquisitions Mergers
4.2.2. New Therapy Launch
4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
4.2.4. Research and Development, Therapy and Regional Expansion
4.3. Price Trend Analysis
4.4. Technology Portfolio

5. Global Antithrombin Market Source Segment Analysis
5.1. Global antithrombin market: Source type overview
5.1.1. Global antithrombin market revenue share, by source, 2016 and 2022
5.2. Human
5.2.1. Global human market , 2016 2022(USD Million)
5.3. Goat milk
5.3.1. Global goat milk market , 2016 2022(USD Million)

6. Global Antithrombin Market Application Segment Analysis
6.1. Global antithrombin market: Application overview
6.1.1. Global antithrombin market revenue share, by application, 2016 2022
6.2. Diagnostics
6.2.1. Global antithrombin market for diagnostics, 2016 2022 (USD Million)
6.3. Therapeutics
6.3.1. Global antithrombin market for therapeutics, 2016 2022(USD Million)
6.4. Research
6.4.1. Global antithrombin market for research, 2016 2022 (USD Million)

7. Global Antithrombin Market Dosage form Segment Analysis
7.1. Global antithrombin market: Dosage form overview
7.1.1. Global antithrombin market revenue share, by dosage form, 2016 and 2022
7.2. Liquid
7.2.1. Global antithrombin market for liquid, 2016 2022 (USD Million)
7.3. Lyophilized
7.3.1. Global antithrombin market for lyophilized, 2016 2022(USD Million)

8. Global Antithrombin Market Regional Segment Analysis
8.1. Global antithrombin market: Regional overview
8.1.1. Global antithrombin market revenue share, by region, 2016 and 2022
8.2. North America
8.2.1. North America antithrombin market revenue, by source, 2014 2022 (USD Million)
8.2.2. North America antithrombin market revenue, by application, 2014 2022 (USD Million)
8.2.3. North America antithrombin market revenue, by dosage form, 2014 2022 (USD Million)
8.2.4. U.S.
8.2.4.1. U.S. antithrombin market revenue, by source, 2014 2022(USD Million)
8.2.4.2. U.S. antithrombin market revenue, by application, 2014 2022(USD Million)
8.2.4.3. U.S. antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.2.5. Canada
8.2.5.1. Canada antithrombin market revenue, by source, 2014 2022(USD Million)
8.2.5.2. Canada antithrombin market revenue, by application, 2014 2022(USD Million)
8.2.5.3. Canada antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.2.6. Rest of North America
8.2.6.1. Rest of North of America antithrombin market revenue, by source, 2014 2022(USD Million)
8.2.6.2. Rest of North of America antithrombin market revenue, by application, 2014 2022(USD Million)
8.2.6.3. Rest of North of America antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3. Europe
8.3.1. Europe antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.2. Europe antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.3. Europe antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.4. Germany
8.3.4.1. Germany antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.4.2. Germany antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.4.3. Germany antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.5. UK
8.3.5.1. UK antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.5.2. UK antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.5.3. UK antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.6. France
8.3.6.1. France antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.6.2. France antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.6.3. France antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.7. Italy
8.3.7.1. Italy antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.7.2. Italy antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.7.3. Italy antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.8. Spain
8.3.8.1. Spain antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.8.2. Spain antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.8.3. Spain antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.3.9. Russia
8.3.9.1. Russia antithrombin market revenue, by source, 2014 2022(USD Million)
8.3.9.2. Russia antithrombin market revenue, by application, 2014 2022(USD Million)
8.3.9.3. Russia antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific antithrombin market revenue, by source, 2014 2022, (USD Million)
8.4.2. Asia Pacific antithrombin market revenue, by application, 2014 2022, (USD Million)
8.4.3. Asia Pacific antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4.4. China
8.4.4.1. China antithrombin market revenue, by source, 2014 2022(USD Million)
8.4.4.2. China antithrombin market revenue, by application, 2014 2022(USD Million)
8.4.4.3. China antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4.5. Japan
8.4.5.1. Japan antithrombin market revenue, by source, 2014 2022(USD Million)
8.4.5.2. Japan antithrombin market revenue, by application, 2014 2022(USD Million)
8.4.5.3. Japan antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4.6. India
8.4.6.1. India antithrombin market revenue, by source, 2014 2022(USD Million)
8.4.6.2. India antithrombin market revenue, by application, 2014 2022(USD Million)
8.4.6.3. India antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4.7. Australia
8.4.7.1. Australia antithrombin market revenue, by source, 2014 2022(USD Million)
8.4.7.2. Australia antithrombin market revenue, by application, 2014 2022(USD Million)
8.4.7.3. Australia antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific antithrombin market revenue, by source, 2014 2022(USD Million)
8.4.8.2. Rest of Asia Pacific antithrombin market revenue, by application, 2014 2022(USD Million)
8.4.8.3. Rest of Asia Pacific antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.5. Latin America
8.5.1. Latin America antithrombin market revenue, by source, 2014 2022(USD Million)
8.5.2. Latin America antithrombin market revenue, by application, 2014 2022(USD Million)
8.5.3. Latin America antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.5.4. Brazil
8.5.4.1. Brazil antithrombin market revenue, by source, 2014 2022(USD Million)
8.5.4.2. Brazil antithrombin market revenue, by application, 2014 2022 (USD Million)
8.5.4.3. Brazil antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.5.5. Mexico
8.5.5.1. Mexico antithrombin market revenue, by source, 2014 2022(USD Million)
8.5.5.2. Mexico antithrombin market revenue, by application, 2014 2022 (USD Million)
8.5.5.3. Mexico antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.5.6. Rest of Latin America
8.5.6.1. Rest of Latin America antithrombin market revenue, by source, 2014 2022(USD Million)
8.5.6.2. Rest of Latin America antithrombin market revenue, by application, 2014 2022 (USD Million)
8.5.6.3. Rest of Latin America antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa antithrombin market revenue, by source, 2014 2022 (USD Million)
8.6.2. Middle East and Africa antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.3. Middle East and Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Saudi Arabia antithrombin market revenue, by source, 2014 2022(USD Million)
8.6.4.2. Saudi Arabia antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.4.3. Saudi Arabia antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6.5. UAE
8.6.5.1. UAE antithrombin market revenue, by source, 2014 2022(USD Million)
8.6.5.2. UAE antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.5.3. UAE antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6.6. South Africa
8.6.6.1. South Africa antithrombin market revenue, by source, 2014 2022(USD Million)
8.6.6.2. South Africa antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.6.3. South Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6.7. Qatar
8.6.7.1. Qatar antithrombin market revenue, by source, 2014 2022(USD Million)
8.6.7.2. Qatar antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.7.3. Qatar antithrombin market revenue, by dosage form, 2014 2022(USD Million)
8.6.8. Rest of Middle East and Africa
8.6.8.1. Rest of Middle East and Africa antithrombin market revenue, by source, 2014 2022(USD Million)
8.6.8.2. Rest of Middle East and Africa antithrombin market revenue, by application, 2014 2022 (USD Million)
8.6.8.3. Rest of Middle East and Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)

9. Company Profile
9.1. Grifols
9.1.1. Overview
9.1.2. Financials
9.1.3. Therapy portfolio
9.1.4. Business strategy
9.1.5. Recent developments
9.2. rEVO Biologics, Inc.
9.2.1. Overview
9.2.2. Financials
9.2.3. Therapy portfolio
9.2.4. Business strategy
9.2.5. Recent developments
9.3. Shire
9.3.1. Overview
9.3.2. Financials
9.3.3. Therapy portfolio
9.3.4. Business strategy
9.3.5. Recent developments
9.4. Kedrion S.p.A
9.4.1. Overview
9.4.2. Financials
9.4.3. Therapy portfolio
9.4.4. Business strategy
9.4.5. Recent developments
9.5. CSL Limited
9.5.1. Overview
9.5.2. Financials
9.5.3. Therapy portfolio
9.5.4. Business strategy
9.5.5. Recent developments
9.6. Scripps Laboratories Inc.
9.6.1. Overview
9.6.2. Financials
9.6.3. Therapy portfolio
9.6.4. Business strategy
9.6.5. Recent developments
9.7. Lee BioSolutions
9.7.1. Overview
9.7.2. Financials
9.7.3. Therapy portfolio
9.7.4. Business strategy
9.7.5. Recent developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll